Nestle Partners With Helaina to Develop Infant Formula With Human Proteins

Nestle is reported to be partnering with U.S. startup Helaina to develop infant formula ingredients based on human-milk proteins, according to a June 2 report syndicated by MarketScreener and attributed to Dow Jones.

The report says the collaboration centers on ingredients for infant formula, but it does not spell out whether the work is at the research, pilot, or commercial stage. Neither Nestle nor Helaina had publicly posted a matching confirmation in the sources reviewed.

Helaina’s website says the company produces effera, a bio-identical lactoferrin made through precision fermentation. The startup also describes its broader platform as focused on human-equivalent proteins for nutrition and positions itself for partner collaborations.

The reported deal lands in a competitive infant-nutrition market where food and biotech companies are trying to add functional proteins and other ingredients that more closely resemble components found in human milk. If confirmed, the partnership would give Nestle access to a startup that is already marketing a human-milk-protein platform to potential customers.

For now, the key unanswered questions are whether Nestle will issue its own statement, what stage of development the collaboration covers, and whether either company will outline a timeline for product work or launch plans.